Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: NZ$0.17 M
• Last 3 months FTD volume: NZ$4.76 M
• Last 12 months FTD volume: NZ$11 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	NZ$56.21 M	NZ$0.12 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	NZ$4.5 M	NZ$68.25 M	🇺🇸 USA
Ultragenyx Pharmaceutical RARE	NZ$3.69 M	NZ$9.48 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	NZ$1.5 M	NZ$12.43 M	🇺🇸 USA
Amicus Therapeutics FOLD	NZ$8.6 M	NZ$17.99 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	NZ$8.34 M	NZ$13.64 M	🇺🇸 USA